Amgen Ventures logo

Amgen Ventures

North America, California, United States, San Francisco

Description

Amgen Ventures is a California-based investment firm focused on early- and late-stage biotechnology companies.

Investor Profile

Amgen Ventures has made 115 investments, with 3 in the past 12 months and 11% as lead.

Stage Focus

  • Series B (32%)
  • Series A (23%)
  • Series C (16%)
  • Series Unknown (10%)
  • Seed (6%)
  • Series D (5%)
  • Series E (3%)
  • Post Ipo Equity (3%)
  • Debt Financing (1%)
  • Private Equity (1%)

Country Focus

  • United States (90%)
  • Singapore (2%)
  • Canada (2%)
  • Israel (2%)
  • United Kingdom (2%)
  • Ireland (2%)
  • Switzerland (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Genetics
  • Life Science
  • Biopharma
  • Information Technology
  • Precision Medicine
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Amgen Ventures frequently co-invest with?

Alexandria Real Estate Equities
North America, California, United States, Pasadena
Co-Investments: 11
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 10
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 13
HealthCare Ventures
North America, Massachusetts, United States, Cambridge
Co-Investments: 9
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 13
Atlas Venture
North America, Massachusetts, United States, Cambridge
Co-Investments: 8
OVP Venture Partners
North America, Washington, United States, Seattle
Co-Investments: 8
Alta Partners
North America, Mississippi, United States, Jackson
Co-Investments: 8
Lilly Ventures
North America, Indiana, United States, Indianapolis
Co-Investments: 8
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 13

Which angels does Amgen Ventures often collaborate with?

David Baszucki
North America, California, United States, San Mateo
Shared Deals: 1
PT
North America, California, United States, San Francisco
Shared Deals: 1
Stephen Thompson
Oceania, Victoria, Australia, Melbourne
Shared Deals: 1
TA
North America, Massachusetts, United States, Cambridge
Shared Deals: 1
GM
North America, Texas, United States, Houston
Shared Deals: 1
GL
North America, Connecticut, United States, Hartford
Shared Deals: 1
AP
North America, New Jersey, United States, Hackensack
Shared Deals: 1
ES
North America, New Jersey, United States, Princeton
Shared Deals: 1

What are some of recent deals done by Amgen Ventures?

EnClear Therapies

Cambridge, Massachusetts, United States

EnClear Therapies is a biotechnology company developing device-based therapies for the treatment of neurodegenerative disease

BiotechnologyTherapeutics
Series UnknownSep 3, 2024
Mindset Medical

Phoenix, Arizona, United States

Mindset Medical is a Health Care Company that develops a platform for clinical information.

Health CareHospitalInformation Technology
Series AJun 6, 2024
Enlaza Therapeutics

La Jolla, California, United States

Enlaza Therapeutics is a biotechnology research company.

BiopharmaBiotechnologyHealth CareTherapeutics
Series AApr 30, 2024
Amount Raised: $100,000,000
BioAge Labs

Richmond, California, United States

BioAge Labs is a clinical-stage biotechnology company that develops therapeutics to treat obesity and metabolic diseases.

BiopharmaBiotechnologyLife ScienceTherapeutics
Series DFeb 13, 2024
Amount Raised: $170,000,000
Seismic Therapeutic

Watertown, Massachusetts, United States

Seismic Therapeutic is a biotechnology company developing machine-learning technology for immunology drug development.

BiotechnologyHealth CareLife ScienceMedical
Series BDec 4, 2023
Amount Raised: $121,000,000
Culmination Bio

Saint George, Utah, United States

Culmination Bio is a startup that is developing a disease-independent patient data intelligence platform.

BiotechnologyHealth Care
Series ANov 30, 2023
Amount Raised: $10,000,000
TileDB

Cambridge, Massachusetts, United States

Modern data stack in a box. All data, code and compute in a single database

AnalyticsBig DataComputerData StorageSoftware
Series BSep 20, 2023
Amount Raised: $34,000,000
ReCode Therapeutics

Dallas, Texas, United States

ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.

BiopharmaBiotechnologyGeneticsPharmaceutical
Series BSep 19, 2023
Amount Raised: $50,000,000
QurAlis

Cambridge, Massachusetts, United States

QurAlis is a biotechnology company that creates precision medicine solutions to cure ALS and FTD.

BiotechnologyGeneticsHealth CarePrecision MedicineTherapeutics
Series BMar 9, 2023
Amount Raised: $88,000,000
Casma Therapeutics

Cambridge, Massachusetts, United States

Casma Therapeutics is a biotechnology company harnessing the natural cellular process of autophagy to design new medicines.

BiotechnologyHealth CareTherapeutics
Series CNov 15, 2022
Amount Raised: $46,000,000